Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.99%
0%
3.99%
6 Months
34.46%
0%
34.46%
1 Year
42.99%
0%
42.99%
2 Years
-23.06%
0%
-23.06%
3 Years
-47.3%
0%
-47.3%
4 Years
117.33%
0%
117.33%
5 Years
-75.65%
0%
-75.65%
Visiomed Group SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
13.05%
EBIT Growth (5y)
16.17%
EBIT to Interest (avg)
-6.54
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
-0.04
Tax Ratio
17.80%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.37%
ROE (avg)
1.75%
Valuation key factors
Factor
Value
P/E Ratio
36
Industry P/E
Price to Book Value
3.24
EV to EBIT
40.37
EV to EBITDA
29.43
EV to Capital Employed
3.24
EV to Sales
4.26
PEG Ratio
0.74
Dividend Yield
NA
ROCE (Latest)
8.02%
ROE (Latest)
8.89%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
17.30
13.70
26.28%
Operating Profit (PBDIT) excl Other Income
2.20
1.20
83.33%
Interest
0.80
1.20
-33.33%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.40
0.90
55.56%
Operating Profit Margin (Excl OI)
32.40%
-55.20%
8.76%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 26.28% vs -4.86% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 55.56% vs 116.98% in Dec 2023
About Visiomed Group SA 
Visiomed Group SA
Pharmaceuticals & Biotechnology
Visiomed Group SA is a France-based company engaged in the design, manufacture and marketing of medical electronics. It develops and markets health products in the fields of medical and well-being self-diagnosis to provide non-drug prevention and treatment solutions. The Company's product portfolio comprises MyThermo, an infrared contact-less medical thermometer; MyTension, an automatic blood pressure and pulse monitors; MyOxy, a finger pulse oximeter; MyECG, a pocket electrodiogram; MyGluco, a blood sugar meter; My Coach, a health and fitness coach, and Epiderm, a telemedicine dermatology mobile application, among others. The Company sells its products to pharmacies, health professionals (hospitals, clinics and retirement homes) and to retail chains. Its brand names include ThermoFlash and BewellConnect, among others.
Company Coordinates 
Company Details
112, Avenue Kleber , PARIS None : 75116
Registrar Details






